S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
PRVA · Privia Health Group, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
Privia Health Group Inc (PRVA)
NASDAQ NMS - GLOBAL MARKET
Health Care
$22.45
-0.48
(-2.09%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$22.45
$22.44
$23.00
52-WEEK RANGE
$22.45
$18.91
$28.82
What's happening
- PRVA is down 2.09% today, trading at $22.45. — Live quote
- Volume today (43,576) is well below its 3-month average of 1,257,910. (Finnhub fundamentals)
- Reports earnings on 2026-11-05 (before market open), 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $0.07 actual vs. $0.07 estimated (+2.3%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 7
Buy 15
Hold 2
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (24 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
PRVA
-3.29%
vs S&P 500
-16.07%
1-YEAR RETURN
PRVA
-13.14%
vs S&P 500
-27.71%
6-MONTH RETURN
PRVA
-2.43%
3-MONTH RETURN
PRVA
-12.85%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$0.07
Est. $0.07
BEAT +2.3%
2026-04-26 (Q1 2026)
$0.02
Est. $0.08
MISS -73.7%
2026-01-26 (Q4 2025)
$0.07
Est. $0.04
BEAT +96.1%
2025-10-26 (Q3 2025)
$0.05
Est. $0.05
MISS -8.9%
Valuation Measures & Ratios
Enterprise Value4$2.46B
Forward P/E550.81
PEG Ratio61.26
Price / Sales (TTM1)1.22
Price / Book74.14
EV4 / Revenue1.04
EV4 / EBITDA43.17
Profit Margin1.19%
Operating Margin1.90%
Return on Equity (ROE8)3.77%
Return on Assets (ROA9)2.00%
Avg Volume (3M)1,257,910
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $3.32B | $3.15B | $3.42B | $3.09B | $3.16B |
| P/E | 153.40 | 187.13 | 197.55 | 222.31 | 222.30 |
| Price/Book | 4.25 | 4.18 | 4.82 | 4.53 | 4.79 |
| EV/EBITDA | 59.49 | 66.74 | 78.72 | — | — |
| ROE | 2.77% | 2.24% | 2.44% | 2.04% | 2.15% |
| ROA | 1.46% | 1.19% | 1.28% | 1.09% | 1.20% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short5,807,295
Change from Prior Settlement+18.51%
% of Float—
Days to Cover (Short Ratio)4.31
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 21.4% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-09-03; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is 1.2%. Finnhub fundamentals ↗
- Trailing 52-week price return is -13.1%. Finnhub market metrics ↗
- Trailing P/E is 102.1, a high price relative to reported earnings. Finnhub fundamentals ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on PRVA
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Operating income | $11.8M | $7.4M | $14.4M | $3.3M | $5.2M | $5.8M | $5.1M | $823.0K |
| Net income | $9.0M | $3.1M | $6.9M | $2.7M | $4.2M | $3.5M | $3.5M | $3.0M |
| EPS (diluted) | $0.07 | $0.02 | $0.05 | $0.02 | $0.03 | $0.03 | $0.03 | $0.02 |
| EPS (basic) | $0.07 | $0.02 | $0.06 | $0.02 | $0.03 | $0.03 | $0.03 | $0.03 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $1.49B | $1.42B | $1.37B | $1.35B | $1.27B | $1.18B | $1.14B | $1.15B |
| Total liabilities | $650.5M | $612.0M | $578.4M | $588.2M | $539.0M | $474.0M | $452.3M | $483.4M |
| Stockholders' equity | $782.3M | $753.1M | $737.2M | $709.1M | $682.9M | $659.4M | $635.2M | $614.9M |
| Total current assets | $1.03B | $966.0M | $911.0M | $970.9M | $883.0M | $886.5M | $834.8M | $853.8M |
| Total current liabilities | $634.4M | $601.3M | $568.5M | $582.9M | $534.9M | $470.8M | $449.1M | $479.5M |
| Cash & equivalents | $412.2M | $419.5M | $479.7M | $441.4M | $390.1M | $469.3M | $491.1M | $422.0M |
| Accounts receivable | $574.2M | $513.7M | $400.9M | $499.0M | $444.0M | $388.7M | $316.2M | $409.0M |
| Property, plant & equipment | $272.0K | $384.0K | $504.0K | $662.0K | $827.0K | $1.0M | $1.2M | $1.5M |
| Goodwill | $215.8M | $209.8M | $209.8M | $172.2M | $172.2M | $141.6M | $141.6M | $139.5M |
| Intangible assets | $218.7M | $212.8M | $215.9M | $167.5M | $170.1M | $108.1M | $109.8M | $103.1M |
| Other non-current assets | $20.6M | $20.6M | $21.0M | $16.9M | $16.6M | $16.9M | $17.1M | $15.0M |
| Accounts payable | $8.5M | $10.6M | $8.0M | $10.2M | $9.0M | $8.0M | $9.8M | $6.9M |
| Accrued liabilities | — | — | — | — | — | — | — | — |
| Other current liabilities | — | — | — | — | — | — | — | — |
| Other non-current liabilities | $5.7M | $3.5M | $2.6M | $1.6M | $0 | $153.0K | $153.0K | $313.0K |
| Common stock & paid-in capital | $1.3M | $1.3M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M |
| Retained earnings | -$144.2M | -$153.2M | -$156.3M | -$165.5M | -$172.3M | -$175.0M | -$179.2M | -$183.6M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.1M | -$49.5M | $127.5M | $52.0M | $8.0M | -$24.1M | $74.8M | $33.2M |
| Investing cash flow | -$11.5M | -$26.0K | -$91.3M | -$1.2M | -$89.1M | $0 | -$6.3M | $0 |
| Financing cash flow | $3.0M | -$10.7M | $2.1M | $431.0K | $1.9M | $2.2M | $619.0K | $1.5M |
| Capital expenditures | — | — | — | — | — | — | — | — |
| Depreciation & amortization | $3.4M | $3.3M | $8.0M | $2.8M | $2.6M | $1.9M | $5.4M | $1.8M |
| Share-based compensation | $19.4M | $21.9M | $15.5M | $19.0M | $18.8M | $17.8M | $15.3M | $15.1M |
| Deferred income taxes | $1.2M | $2.5M | $1.5M | $6.7M | $958.0K | $1.7M | $1.2M | $3.7M |
| Change in accounts receivable | $59.6M | $112.8M | -$139.9M | $55.0M | $48.9M | $72.5M | -$98.4M | $38.9M |
| Change in accounts payable | $10.5M | -$16.2M | $12.1M | $10.4M | $6.2M | -$13.8M | $12.1M | $4.8M |
| Other investing activities | $33.0K | $26.0K | $0 | $1.2M | $0 | $0 | $15.0K | $0 |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating income | $34.2M | $17.0M | $20.6M | -$19.1M | -$217.4M |
| Net income | $22.9M | $14.4M | $23.1M | -$8.6M | -$188.2M |
| EPS (diluted) | $0.18 | $0.11 | $0.19 | $-0.08 | $-1.83 |
| EPS (basic) | $0.19 | $0.12 | $0.20 | $-0.08 | $-1.83 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $1.37B | $1.14B | $999.9M | $792.8M | $686.4M |
| Total liabilities | $578.4M | $452.3M | $392.5M | $273.8M | $236.2M |
| Stockholders' equity | $737.2M | $635.2M | $561.4M | $499.1M | $426.9M |
| Total current assets | $911.0M | $834.8M | $700.8M | $552.0M | $446.7M |
| Total current liabilities | $568.5M | $449.1M | $387.0M | $264.3M | $190.5M |
| Cash & equivalents | $479.7M | $491.1M | $389.5M | $348.0M | $320.6M |
| Accounts receivable | $400.9M | $316.2M | $290.8M | $189.6M | $117.4M |
| Property, plant & equipment | $504.0K | $1.2M | $2.3M | $3.4M | $4.5M |
| Goodwill | $209.8M | $141.6M | $138.7M | $126.9M | $127.9M |
| Intangible assets | $215.9M | $109.8M | $107.6M | $57.4M | $59.7M |
| Other non-current assets | $21.0M | $17.1M | $8.6M | $4.7M | $4.5M |
| Accounts payable | $8.0M | $9.8M | $7.9M | $6.7M | $3.0M |
| Other non-current liabilities | $2.6M | $153.0K | $313.0K | $1.0M | $3.0M |
| Common stock & paid-in capital | $1.2M | $1.2M | $1.2M | $1.1M | $1.1M |
| Retained earnings | -$156.3M | -$179.2M | -$193.6M | -$216.7M | -$208.1M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $163.4M | $109.3M | $80.8M | $47.2M | $55.1M |
| Investing cash flow | -$181.6M | -$12.0M | -$43.0M | -$104.0K | -$32.8M |
| Financing cash flow | $6.7M | $4.3M | $3.7M | -$19.7M | $213.7M |
| Free cash flow | — | — | $80.7M | $47.1M | $54.5M |
| Capital expenditures | — | — | $113.0K | $104.0K | $547.0K |
| Depreciation & amortization | $9.9M | $7.3M | $6.5M | $4.6M | $2.5M |
| Share-based compensation | $71.1M | $56.7M | $37.1M | $67.4M | $253.5M |
| Deferred income taxes | $10.9M | $8.8M | $7.5M | -$7.0M | -$28.4M |
| Change in accounts receivable | $36.7M | $19.8M | $96.9M | $72.2M | $14.6M |
| Change in accounts payable | $14.8M | $19.9M | $5.0M | $6.9M | $1.3M |
| Other investing activities | $1.2M | $5.0M | $113.0K | $104.0K | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding PRVA as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-03-12 to 2026-09-01
Recent transactions
- Insiders have net sold 614,353 shares over the last 182 days, across 0 purchases and 18 sales.
- Most recent: Ernest Opella Finley (Director) — Grant / award of 6,350 shares on 2026-09-01.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)614,353 sh(18 txns)
Net Shares-614,353
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Ernest Opella Finley | Director | Grant / award | 2026-09-01 | 6,350 |
| Mountcastle David | EVP & Chief Financial Officer | Open market sale | 2026-07-09 | 21,275 |
| Morris Matthew Shawn | Director | Option exercise | 2026-07-06 | 53,722 |
| SOISTMAN FRANCIS S JR | Director | Grant / award | 2026-05-20 | 8,463 |
| BERBERIAN LANCE | Director | Grant / award | 2026-05-20 | 8,463 |
| COCOZZA NANCY G | Director | Grant / award | 2026-05-20 | 8,463 |
| Kimmet Pamela O | Director | Grant / award | 2026-05-20 | 8,463 |
| McCarthy Thomas A | Director | Grant / award | 2026-05-20 | 8,463 |
| Ryu Jaewon | Director | Grant / award | 2026-05-20 | 8,463 |
| KING DAVID P | Director | Grant / award | 2026-05-20 | 8,463 |
| Mehrotra Parth | Chief Executive Officer | Open market sale | 2026-05-12 | 15,647 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-01 | Ernest Opella Finley | Director | Grant / award | 6,350 | $0.00 |
| 2026-07-09 | Mountcastle David | EVP & Chief Financial Officer | Open market sale | 21,275 | $27.67 |
| 2026-07-07 | Mountcastle David | EVP & Chief Financial Officer | Open market sale | 600 | $27.57 |
| 2026-07-06 | Morris Matthew Shawn | Director | Option exercise | 53,722 | $2.00 |
| 2026-07-06 | Morris Matthew Shawn | Director | Open market sale | 53,722 | $27.24 |
| 2026-07-02 | Morris Matthew Shawn | Director | Option exercise | 59,037 | $2.00 |
| 2026-07-02 | Morris Matthew Shawn | Director | Open market sale | 59,037 | $27.33 |
| 2026-07-02 | Mountcastle David | EVP & Chief Financial Officer | Open market sale | 24,734 | $27.50 |
| 2026-07-01 | Morris Matthew Shawn | Director | Option exercise | 82,675 | $2.00 |
| 2026-07-01 | Morris Matthew Shawn | Director | Open market sale | 45,634 | $26.52 |
| 2026-07-01 | Morris Matthew Shawn | Director | Open market sale | 37,041 | $26.93 |
| 2026-06-30 | Morris Matthew Shawn | Director | Option exercise | 52,823 | $2.00 |
| 2026-06-30 | Morris Matthew Shawn | Director | Open market sale | 52,823 | $25.72 |
| 2026-06-29 | Morris Matthew Shawn | Director | Option exercise | 63,212 | $2.00 |
| 2026-06-29 | Morris Matthew Shawn | Director | Open market sale | 63,212 | $25.33 |
| 2026-06-26 | Morris Matthew Shawn | Director | Option exercise | 88,110 | $2.00 |
| 2026-06-26 | Morris Matthew Shawn | Director | Open market sale | 88,110 | $25.33 |
| 2026-06-26 | Mountcastle David | EVP & Chief Financial Officer | Option exercise | 17,196 | $2.00 |
| 2026-06-26 | Mountcastle David | EVP & Chief Financial Officer | Open market sale | 17,196 | $25.18 |
| 2026-05-20 | SOISTMAN FRANCIS S JR | Director | Grant / award | 8,463 | $0.00 |
| 2026-05-20 | BERBERIAN LANCE | Director | Grant / award | 8,463 | $0.00 |
| 2026-05-20 | COCOZZA NANCY G | Director | Grant / award | 8,463 | $0.00 |
| 2026-05-20 | Kimmet Pamela O | Director | Grant / award | 8,463 | $0.00 |
| 2026-05-20 | McCarthy Thomas A | Director | Grant / award | 8,463 | $0.00 |
| 2026-05-20 | Morris Matthew Shawn | Director | Grant / award | 8,463 | $0.00 |
| 2026-05-20 | Ryu Jaewon | Director | Grant / award | 8,463 | $0.00 |
| 2026-05-20 | KING DAVID P | Director | Grant / award | 8,463 | $0.00 |
| 2026-05-12 | Mehrotra Parth | Chief Executive Officer | Open market sale | 15,647 | $22.64 |
| 2026-05-11 | Mehrotra Parth | Chief Executive Officer | Open market sale | 105,439 | $22.55 |
| 2026-05-11 | Mountcastle David | EVP & Chief Financial Officer | Open market sale | 3,385 | $22.60 |
| 2026-05-04 | Mountcastle David | EVP & Chief Financial Officer | Option exercise | 1,206 | $2.00 |
| 2026-05-04 | Mountcastle David | EVP & Chief Financial Officer | Open market sale | 1,206 | $25.00 |
| 2026-05-04 | Morris Matthew Shawn | Director | Option exercise | 1,017 | $2.00 |
| 2026-05-04 | Morris Matthew Shawn | Director | Open market sale | 1,017 | $24.96 |
| 2026-05-01 | Mountcastle David | EVP & Chief Financial Officer | Option exercise | 7,179 | $2.00 |
| 2026-05-01 | Mountcastle David | EVP & Chief Financial Officer | Open market sale | 7,179 | $25.03 |
| 2026-05-01 | Morris Matthew Shawn | Director | Option exercise | 17,096 | $2.00 |
| 2026-05-01 | Morris Matthew Shawn | Director | Open market sale | 17,096 | $24.99 |
| 2026-04-02 | Mountcastle David | EVP & Chief Financial Officer | Open market sale | 5,566 | $20.85 |
| 2026-03-16 | Mountcastle David | EVP & Chief Financial Officer | Open market sale | 6,391 | $22.11 |
| 2026-03-16 | Mehrotra Parth | Chief Executive Officer | Open market sale | 26,509 | $22.11 |
| 2026-03-13 | Mountcastle David | EVP & Chief Financial Officer | Open market sale | 6,565 | $21.52 |
| 2026-03-13 | Mehrotra Parth | Chief Executive Officer | Open market sale | 27,229 | $21.52 |
| 2026-03-12 | Mountcastle David | EVP & Chief Financial Officer | Open market sale | 6,453 | $21.90 |
| 2026-03-12 | Mehrotra Parth | Chief Executive Officer | Open market sale | 26,763 | $21.90 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 04:14 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-03 | 4 | 2026-09-01 | View on SEC.gov → |
| 2026-08-18 | 8-K | 2026-08-12 | View on SEC.gov → |
| 2026-08-06 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-06 | 8-K | 2026-08-06 | View on SEC.gov → |
| 2026-07-13 | 4 | 2026-07-09 | View on SEC.gov → |
| 2026-07-09 | 4 | 2026-07-07 | View on SEC.gov → |
| 2026-07-07 | 8-K | 2026-07-06 | View on SEC.gov → |
| 2026-07-07 | 4 | 2026-07-02 | View on SEC.gov → |
| 2026-07-07 | 4 | 2026-07-02 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-06-30 | View on SEC.gov → |
| 2026-06-30 | 4 | 2026-06-26 | View on SEC.gov → |
| 2026-06-30 | 4 | 2026-06-26 | View on SEC.gov → |
Recent news
Headlines about PRVA (Privia Health Group, Inc.). Links open the publisher — we don’t host full articles.
-
Privia Health Group, Inc. (PRVA) Stock Forecasts
Yahoo Finance · 2026-10-21 -
2 Profitable Stocks for Long-Term Investors and 1 We Ignore
Yahoo · 2026-10-19 -
Learn Why The Bull Case For Privia Health Group (PRVA) Could Change Following In Network Renewal
Simply Wall Street · 2026-10-16 -
3 US Healthcare Automation Stocks Riding The Push To Cut Admin Costs
Yahoo · 2026-10-10 -
Privia Health to Report Third Quarter 2026 Results on Thursday, November 5
Yahoo · 2026-10-08 -
3 Stocks Under $50 We Keep Off Our Radar
Yahoo Finance · 2026-10-05 -
2 Growth Stocks to Stash and 1 We Turn Down
Yahoo Finance · 2026-09-30 -
Why Privia Health Group (PRVA) Is Getting Attention Now
Yahoo Finance · 2026-09-19
No headlines in this category right now — try “All”.